Rubicon Research P/E Ratio

Current P/E Ratio
85.2
High Valuation
Very High - High growth expectations or significantly overvalued

Rubicon Research P/E ratio. Rubicon Research (RUBICON) P/E ratio is 85.2 (High), EPS (TTM) ₹15.52, current price ₹1722.30 on NSE vs historical average P/E of 45.71 (100.0th percentile) — Very High - High growth expectations or significantly overvalued. Also explore RUBICON share price charts to track price trends across different timeframes.

Current Valuation Metrics

P/E Ratio 85.2
Current Price ₹1722.30
EPS (TTM) ₹15.52
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 45.71
Historical Range 45.71 - 45.71
Percentile 100.0%

Sector Context

Sector Average 52.06
Sector Median 29.4
Sector Rank #11 of 255
Sector Percentile 4.3%

Earnings Breakdown (TTM)

TTM EPS ₹18.77
Sept 2026 ₹5.47
Mar 2026 ₹4.68

RUBICON P/E Ratio — Valuation Signal & Historical Context

Rubicon Research P/E 85.2 vs historical average 45.71, range 45.71–45.71 — signal: Overvalued. Check Rubicon Research marketcap in USD to track the company's total market size over time.

  • Stock appears overvalued with PE of 85.2, suggesting caution for new investments
  • Current PE is 86.4% above historical average
  • Trading at premium to sector average PE of 52.06

Rubicon Research P/E Ratio Historical Trend

RUBICON annual price-to-earnings ratio — 1 years, EPS and year-end price. Current P/E 85.2 vs historical average 45.71. For live price, revenue and the complete fundamental profile, see Rubicon Research share price today.

RUBICON Historical P/E Ratio — EPS, Year-End Price & Valuation

Rubicon Research annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 45.71 13.13 ₹600.15 NSE High

RUBICON vs Healthcare Peers — P/E Ratio Comparison

Rubicon Research P/E 85.2 vs Healthcare average 52.06, median 29.4 — range 2.0–733.0.

Sector Average
52.06
Sector Median
29.4
Lowest P/E
2.0
Highest P/E
733.0
Companies
255
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Sunrest Lifescience SUNREST 2.0 ₹72 Low
Brooks Laboratories BROOKS 2.6 ₹206 Low
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.3 ₹54 Low
Sun Pharma Advanced Rese… SPARC 4.1 ₹6,355 Low
Dipna Pharmachem DPL 4.5 ₹11 Low
JFL Life Sciences JFLLIFE 4.7 ₹82 Low
Royal Sense ROYAL 4.8 ₹34 Low
Star Imaging And Path Lab STARIMAGIN 5.3 ₹110 Low
Kabra Drugs KABRADG 6.3 ₹49 Low